Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CAVA GROUP, INC.CAVA · Entity 756 | Director | June 22, 2026 | June 24, 2026 |
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | Director | June 03, 2026 | June 04, 2026 |
| WW INTERNATIONAL, INC.WTW · Entity 6479 | Director | January 02, 2019 | January 04, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CAVA GROUP, INC.
Report date June 22, 2026 · Filed June 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 19,955 |
Reported balance
After 2026-06-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-22 · Grant · Acquired 1,881 · Balance 19,955 F1: Reflects a grant of restricted stock units ("RSUs"), which vest in full on the earlier of (i) June 22, 2027 and (ii) the business day before the date of the next annual meeting of the stockholders of CAVA Group Inc. (the "Issuer"), subject to the reporting person's continued service through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.0001 per share upon settlement. F2: Includes unvested RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units ("RSUs"), which vest in full on the earlier of (i) June 22, 2027 and (ii) the business day before the date of the next annual meeting of the stockholders of CAVA Group Inc. (the "Issuer"), subject to the reporting person's continued service through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.0001 per share upon settlement.
F2: Includes unvested RSUs.
LEXICON PHARMACEUTICALS, INC.
Report date June 03, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 374,486 |
Reported balance
After 2026-06-03 transaction · row 1
1 source rowRow 1 · 2026-06-03 · Exercise / conversion · Acquired 89,312 · Balance 374,486 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-06-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-03 · Exercise / conversion · Disposed 89,312 · Balance 0 F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2: Each restricted stock unit represents a contingent right to receive one share of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2: Each restricted stock unit represents a contingent right to receive one share of common stock.
WW INTERNATIONAL, INC.
Report date January 02, 2019 · Filed January 04, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 47,484 |
Reported balance
After 2019-01-02 transaction · row 1
1 source rowRow 1 · 2019-01-02 · Grant · Acquired 453 · Balance 47,484 F1: The shares listed represent shares of Common Stock subject to transfer restrictions. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares listed represent shares of Common Stock subject to transfer restrictions.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Blue Buffalo Pet Products, Inc.
Report date April 24, 2018 · Filed April 24, 2018
Section 16 reporting ended · disclosed 2018-04-24. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-04-24 transaction · row 1
1 source rowRow 1 · 2018-04-24 · Disposition to issuer · Disposed 10,569 · Balance 0 F1: On April 24, 2018, General Mills, Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Bravo Merger Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of February 22, 2018 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). F2: At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $40.00 in cash, without interest and after giving effect to any required withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: On April 24, 2018, General Mills, Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Bravo Merger Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of February 22, 2018 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger").
F2: At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $40.00 in cash, without interest and after giving effect to any required withholding taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 03, 2017 Filed Apr 5, 2017 20:08 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 1,216 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-025584 · doc4.xml · nonDerivative · entry 1 Amouyal Philippe · CIK 0001376854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,893 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 20:31 UTC | Blue Buffalo Pet Products, Inc. BUFF · Entity 167336 | GrantCommon Stock | 3,695 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-009257 · doc4.xml · nonDerivative · entry 1 Amouyal Philippe · CIK 0001376854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,569 F1 · kind: Represents a grant of restricted stock that is fully vested. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:13 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 804 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-002007 · doc4.xml · nonDerivative · entry 1 Amouyal Philippe · CIK 0001376854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,677 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 21:06 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-155875 · doc4.xml · nonDerivative · entry 1 Amouyal Philippe · CIK 0001376854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,873 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:14 UTC | WW INTERNATIONAL, INC. WTW · Entity 6479 | GrantCommon Stock | 904 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-144892 · doc4.xml · nonDerivative · entry 1 Amouyal Philippe · CIK 0001376854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,873 F1 · shares: The shares listed represent shares of Common Stock subject to transfer restrictions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.